Report AMR

About AMR

The usage of antimicrobials causes bacteria or pathogens to change over time and makes antimicrobial pharmaceuticals less effective. This process is called antimicrobial resistance (AMR). When AMR infections occur and antimicrobials become ineffective, these infections can in the worst cases be fatal. In Japan and overseas, more and more microbes are developing AMR. If the current situation continues unabated, the annual number of deaths due to AMR infections is projected to increase to about 10 million people globally by 2050.
HGPI issued calls for action on this issue and AMR Alliance Japan was established in November 2018 with the goal of driving discussions and promoting policies for AMR with representatives from industry, Government, academia, and civil society. In its role as secretariat of AMR Alliance Japan, HGPI works to formulate policy recommendations and to see those recommendations implemented.

[Policy Recommendations] Requests for the FY2022 Revision of the Medical Service Fee Schedule for the Control of Antimicrobial Resistance (October 12, 2021)
2021-10-13

[Policy Recommendations] Requests for the FY2022 Revision of the Medical Service Fee Sch ...>>

[Case Study] Shogo Otake and Masashi Kasai “AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria” (AMR Alliance Japan, October 12, 2021)
2021-10-12

[Case Study] Shogo Otake and Masashi Kasai “AMR can affect newborns! A 5-month-old boy w ...>>

2021-09-29

[In the Media] ”Discussion around AMR（Antimicrobial Resistance）at International Symposiu ...>>

[Case Study] Keiji Okinaka “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment” (AMR Alliance Japan, September 6, 2021 )
2021-09-06

[Case Study] Keiji Okinaka “A disseminated filamentous fungal infection that broke throu ...>>

2021-08-20

[In the Media] “Japan should follow US efforts to develop new antibiotics” (NIKKEI ASIA, ...>>

[Event Report] The Sixth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (July 7, 2021)
2021-08-18

[Event Report] The Sixth Meeting of the AMR Consortium of the Nikkei FT Communicable Dis ...>>

[Event Report] The Fourth Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (June 30, 2021)
2021-08-18

[Event Report] The Fourth Meeting of Working Group 2 Under the Sub-committee on AMR of t ...>>

[Event Report] The Second Roundtable Discussion “Examining Numeric Targets for AMR Countermeasures – Setting Appropriate Performance Indicators in the Next AMR Action Plan” (June 30, 2021)
2021-08-16

[Event Report] The Second Roundtable Discussion “Examining Numeric Targets for AMR Count ...>>

[Event Report] The First Roundtable Discussion “Examining Numeric Targets for AMR Countermeasures – Setting Appropriate Performance Indicators in the Next AMR Action Plan” (June 21, 2021)
2021-08-16

[Event Report] The First Roundtable Discussion “Examining Numeric Targets for AMR Counte ...>>

[Recommendations] AMR Alliance Japan Recommendations Toward Stronger AMR Countermeasures in the 2021 Basic Policies for Economic and Fiscal Management and Reform (June 10, 2021)
2021-06-10

[Recommendations] AMR Alliance Japan Recommendations Toward Stronger AMR Countermeasures ...>>

[Event Report] The Second Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (May 28, 2021)
2021-05-30

[Event Report] The Second Meeting of Working Group 3 Under the Sub-committee on AMR of t ...>>

[Event Report] Non-partisan Diet Member Briefing – Creating Pull Incentives to Spur the Development of Antimicrobials (April 22, 2021)
2021-04-22

[Event Report] Non-partisan Diet Member Briefing – Creating Pull Incentives to Spur the ...>>

PageTop